Overall Winner: Harrison.ai·68/ 100

Harrison.ai vs Regard AI

In-depth comparison — valuation, funding, investors, founders & more

Winner
H
Harrison.ai

🇦🇺 Australia · Aengus Tran

Series CAI HealthcareEst. 2018

Valuation

N/A

Total Funding

$129M

68
Awaira Score68/100

100-500 employees

Full Harrison.ai Profile →
R
Regard AI

🇺🇸 United States

Series BAI HealthcareEst. 2017

Valuation

N/A

Total Funding

$30M

55
Awaira Score55/100

50-200 employees

Full Regard AI Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Harrison.ai and Regard AI compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Harrison. Regard AI builds an AI clinical documentation assistant that integrates with hospital electronic health record systems to automatically identify potential diagnoses, surface relevant clinical evidence from patient records, and generate structured documentation for physician review.

Neither company has publicly disclosed a valuation at this time. On the funding side, Harrison.ai has raised $129M in total — $99M more than Regard AI's $30M.

Regard AI has 1 year more market experience, having been founded in 2017 compared to Harrison.ai's 2018 founding. In terms of growth stage, Harrison.ai is at Series C while Regard AI is at Series B — a meaningful difference for investors evaluating risk and upside.

Harrison.ai operates out of 🇦🇺 Australia while Regard AI is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Harrison.ai leads with a score of 68, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricHarrison.aiRegard AI
💰Valuation
N/A
N/A
📈Total Funding
$129MWINS
$30M
📅Founded
2018WINS
2017
🚀Stage
Series C
Series B
👥Employees
100-500
50-200
🌍Country
Australia
United States
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
68WINS
55

Key Differences

📈

Funding gap: Harrison.ai has raised $99M more ($129M vs $30M)

📅

Market experience: Regard AI has 1 year more (founded 2017 vs 2018)

🚀

Growth stage: Harrison.ai is at Series C vs Regard AI at Series B

👥

Team size: Harrison.ai has 100-500 employees vs Regard AI's 50-200

🌍

Market base: 🇦🇺 Harrison.ai (Australia) vs 🇺🇸 Regard AI (United States)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Harrison.ai scores 68/100 vs Regard AI's 55/100

Which Should You Choose?

Use these signals to make the right call

H

Choose Harrison.ai if…

Top Pick
  • Higher Awaira Score — 68/100 vs 55/100
  • Stronger investor backing — raised $129M
  • Australia-based for regional compliance or proximity
  • Harrison
R

Choose Regard AI if…

  • More market experience — founded in 2017
  • United States-based for regional compliance or proximity
  • Regard AI builds an AI clinical documentation assistant that integrates with hospital electronic health record systems to automatically identify potential diagnoses, surface relevant clinical evidence from patient records, and generate structured documentation for physician review

Users Also Compare

FAQ — Harrison.ai vs Regard AI

Is Harrison.ai bigger than Regard AI?
Neither company has publicly disclosed a valuation, making a definitive size comparison difficult. Harrison.ai employs 100-500 people, while Regard AI has 50-200 employees.
Which company raised more funding — Harrison.ai or Regard AI?
Harrison.ai has raised more in total funding at $129M, compared to Regard AI's $30M — a gap of $99M.
Which company has a higher Awaira Score?
Harrison.ai holds the higher Awaira Score at 68/100, compared to Regard AI's 55/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 13-point gap that reflects meaningful differences in scale or traction.
Who founded Harrison.ai vs Regard AI?
Harrison.ai was founded by Aengus Tran in 2018. Regard AI's founder information is not currently available in our database.
What does Harrison.ai do vs Regard AI?
Harrison.ai: Harrison.ai develops AI radiology and pathology analysis software for clinical deployment, building FDA-cleared and TGA-registered algorithms for chest X-ray abnormality detection, CT pulmonary angiography analysis, and mammography screening under its Annalise.ai product brand. The Sydney company focuses on AI clinical decision support that helps radiologists prioritise worklists, detect abnormalities, and reduce reporting errors in high-volume radiology departments.\n\nThe company raised approximately $129 million including a Series C from investors including Blackbird Ventures, Skip Capital, and Telstra Ventures. Harrison.ai has deployed its Annalise.ai platform across Australian hospital networks and has received US FDA clearance for its chest X-ray AI product, enabling international commercial expansion beyond Australia. The company has published clinical validation studies demonstrating AI performance that is non-inferior to specialist radiologist reads on chest X-ray abnormality detection across multiple institutions.\n\nHarrison.ai competes in the AI radiology market against Aidoc, Lunit, Qure.ai, and Behold.ai, which all target radiologist workflow assistance and clinical alerting. The Australian healthcare market provides a strong home base given the National Health Service framework and centrally coordinated radiology procurement, while FDA clearance opens the substantially larger US radiology AI market. The company is considered one of Australia most promising medical AI companies and a flagship for the Australian healthcare technology ecosystem. Regard AI: Regard AI builds an AI clinical documentation assistant that integrates with hospital electronic health record systems to automatically identify potential diagnoses, surface relevant clinical evidence from patient records, and generate structured documentation for physician review. The system is designed to reduce the documentation burden on hospitalists and clinical teams while improving diagnostic completeness and coding accuracy.\n\nThe company raised approximately 30 million USD and has deployed across hospital systems focused on reducing physician administrative load, a problem that contributes to clinician burnout and documentation errors with downstream billing and quality implications. Regard operates as a background analysis layer that surfaces findings without requiring clinicians to change their existing EHR workflow.\n\nClinical documentation AI sits at the intersection of physician workflow optimization and revenue cycle management, giving it a dual value proposition that justifies enterprise procurement from both clinical operations and hospital finance departments. Regard competes with Nuance DAX, Abridge, and other ambient documentation tools, but its focus on diagnostic suggestion and coding completeness rather than pure transcription differentiates its clinical and financial value story.
Which company was founded first?
Regard AI was founded first in 2017, giving it 1 year of additional market experience. Harrison.ai was founded later in 2018. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Harrison.ai has approximately 100-500 employees, while Regard AI has approximately 50-200. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Harrison.ai and Regard AI competitors?
Yes, Harrison.ai and Regard AI are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.